Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion

Chest

Volumn 137, Issue 3, 2010, Pages 516-520

  Steiner, Stephan ^a   Schueller, Per Otto ^a   Schulze, Volker ^a   Strauer, Bodo Eckehard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; DEMOGRAPHY; DISEASE COURSE; HEART INFARCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; PREVALENCE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE;

EID: 77949517064     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1136     Document Type: Article

References (35)

1. Steiner S, Strauer BE. Obstructive sleep apnea and coronary artery disease. Evidence for a causal relationship. In: Lang A, ed. Sleep Apnea Syndrome Research Focus. New York, NY; Nova Science Publishers; 2007; 1-13.
2. Mooe T, Franklin K, Holmstrom K, et al. Sleep-disordered breathing and coronary artery disease: long- term prognosis. Am J Respir Crit Care Med. 2001;164(10):1910-1913.
3. Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep apnea treatment in coronary artery disease: a long term follow-up study. Eur Heart J. 2004;25(9):728-734.
4. Gamis A, Howard D, Olson E, et al. Day-night pattern of sudden death in obstructive sleep apnea. New Engl J Med. 2005;352:1206-1214.
5. Schulz R. The vascular micromilieu in obstructive sleep apnoea. Eur Respir J. 2005; 25(5): 780-782.
6. Fletcher EC. Sympathetic activity and blood pressure in the sleep apnea syndrome. Respiration. 1997; 64(suppl 1): 22-28.
7. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest. 1993; 103(3): 722-727.
8. Jelic S, Padeletti M, Kawut SM, et al. Infl ammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008;117(17):2270-2278.
9. Shamsuzzaman ASM, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002; 105(21): 2462-2464.
10. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003; 107(8): 1129-1134.
11. Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer BE. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology. 2005;104(2):92-96.
12. Lavie L, Lavie P. Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Medical Hypotheses. 2006; 66(6):1069-1073.
13. Schultz A, Lavie L, Hochberg I, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation. 1999; 100(5): 547-552.
14. Peled N, Shitrit D, Bendayan D, Peled E, Kramer MR. Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity. Respiration. 2007; 74(1): 50-55.
15. Abaci A, Oguzhan A, Kahraman S et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999; 99(17): 2239-2242.
16. Rzeczuch K, Jagielski D, Kołodziej A, et al. Coronary collateral circulation is less developed when ischaemic heart disease coexists with diabetes. Kardiol Pol. 2003; 58(2): 85-92.
17. Turhan H, Yasar AS, Erbay AR, Yetkin E, Sasmaz H, Sabah I. Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron Artery Dis. 2005; 16(5): 281-285.
18. Yilmaz MB, Biyikoglu SF, Akin Y, Guray U, Kisacik HL, Korkmaz S. Obesity is associated with impaired coronary collateral vessel development. Int J Obes Relat Metab Disord. 2003; 27(12): 1541-1545.
19. Topsakal R, Eryol NK, Abaci A, et al. The relation between chronic obstructive pulmonary disease and coronary collateral vessels. Angiology. 2005; 56(6): 651-656.
20. Dincer I, Ongun A, Turhan S, Ozdol C, Kumbasar D, Erol C. Association between the dosage and duration of statin treatment with coronary collateral development. Coron Artery Dis. 2006; 17(6): 561-565.
21. Peker Y, Hedner J, Kraiczi H, Löth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med. 2000;162(1):81-86.
22. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation. 1986; 74(3): 469-476.
23. Koerselman J, van der Graaf Y, de Jaegere P, Grobbee DE. Coronary collaterals. An important and underexposed aspect of coronary artery disease. Circulation. 2003; 107(19): 2507-2511.
24. Charney R, Cohen M. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J. 2009; 126 (4): 937-945.
25. Fukai M, Ii M, Nakakoji T, et al. Angiographically demonstrated coronary collaterals predict residual viable myocardium in patients with chronic myocardial infarction: a regional metabolic study. J Cardiol. 2000; 35(2): 103-111.
26. Fruhmann G. Hypersomnia with primary hypoventilation syndrome and following cor pulmonale. Bull Physio-Path Resp (Nancy). 1972; 8(5): 1173-1179.
27. Steiner S, Schueller P, Hennersdorf M, et al. Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res. 2008; 9(1): 50.
28. Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med. 2007; 176(12): 1274-1280.
29. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988; 94(1): 9-14.
30. Lavie P. Mortality in sleep apnea syndrome. Eur Respir Rev. 2007; 16(106): 203-210.
31. Lavie P, Lavie L. Unexpected survival advantage in elderly people with moderate sleep apnea. J Sleep Res. 2009;18(4):397-403.
32. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med. 2002;165(1):67-70.
33. Demirbag R, Gur M, Yilmaz R, Kunt AS, Erel O, Andac MH. Infl uence of oxidative stress on the development of collateral circulation in total coronary occlusions. Int J Cardiol. 2007; 116(1): 14-19.
34. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000; 165(2): 556- 570.
35. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax. 2000; 55(12): 1046-1051.